Showing results (141-150 of 156) with videos related to

Sort By:
Pageof 16
Photodiagnosis and Photodynamic Therapy|November 9, 2017
Lesion oxygenation associates with clinical outcomes in premalignant and early stage head and neck tumors treated on a phase 1 trial of photodynamic therapyPeter H Ahn, Jarod C Finlay, Shannon M Gallagher-Colombo, et al.
Cancer Research Communications|May 7, 2025
PD-1 Blockade Mitigates Surgery-Induced Immunosuppression and Increases the Efficacy of Photodynamic Therapy for Pleural MesotheliomaGwendolyn M Cramer, Richard W Davis, Emmanouil Papasavvas, et al.
International Journal of Radiation Oncology, Biology, Physics|January 14, 2020
Design, Implementation, and in Vivo Validation of a Novel Proton FLASH Radiation Therapy SystemEric S Diffenderfer, Ioannis I Verginadis, Michele M Kim, et al.
Clinical Lung Cancer|January 9, 2024
Plunging Into the PACIFIC: Outcomes of Patients With Unresectable KRAS-Mutated Non-Small Cell Lung Cancer Following Definitive Chemoradiation and Durvalumab ConsolidationAdam Barsouk, Cole Friedes, Michelle Iocolano, et al.
JAMA Network Open|March 10, 2023
Clinical Outcomes Associated With Pembrolizumab Monotherapy Among Adults With Diffuse Malignant Peritoneal MesotheliomaMelina E Marmarelis, Xiao Wang, Leonid Roshkovan, et al.
International Journal of Radiation Oncology, Biology, Physics|August 24, 2023
Pneumonitis Rates Before and After Adoption of Immunotherapy Consolidation in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Concurrent ChemoradiationNikhil Yegya-Raman, Cole Friedes, Sang Ho Lee, et al.
Biorxiv : the Preprint Server for Biology|July 19, 2024
FLASH proton reirradiation, with or without hypofractionation, mitigates chronic toxicity in the normal murine intestine, skin, and boneIoannis I Verginadis, Anastasia Velalopoulou, Michele M Kim, et al.
Heart Rhythm|October 12, 2023
One-year outcomes after stereotactic body radiotherapy for refractory ventricular tachycardiaJeffrey Arkles, Tim Markman, Rachel Trevillian, et al.
Clinical Lung Cancer|April 19, 2023
Utilization and Factors Precluding Receipt of Checkpoint Inhibitor Consolidation for Stage III NSCLC in a Large US Academic Health SystemNikhil Yegya-Raman, Cole Friedes, Lova Sun, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 29, 2025
FLASH proton reirradiation, with or without hypofractionation, reduces chronic toxicity in the normal murine intestine, skin, and boneIoannis I Verginadis, Anastasia Velalopoulou, Michele M Kim, et al.
Pageof 16